LBSL | LTBL | AARS2 | |
---|---|---|---|
Mean age at onset (age range) | 8 years (5 months–40 years) | 6 months (birth–16 months) | 25 years (1.5–44 years) |
Rate of disease progression | Slow, gradual > rapid decline | Biphasic with stability or improvement after early “hit” | Rapid decline within a few years |
Risk of disability | Greater disability associated with earlier age of onset | Greater disability associated with initial clinical and imaging severity | High risk of motor and cognitive impairment |
Risk of mortality | Increased for infantile-onset disease, otherwise low | Increased for early onset, severe disease with multi-organ involvement | Increased risk from late disease complications |